These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
641 related articles for article (PubMed ID: 18327814)
1. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas. Angileri FF; Aguennouz M; Conti A; La Torre D; Cardali S; Crupi R; Tomasello C; Germanò A; Vita G; Tomasello F Cancer; 2008 May; 112(10):2258-66. PubMed ID: 18327814 [TBL] [Abstract][Full Text] [Related]
2. Expression of the tumor necrosis factor receptor-associated factors 1 and 2 and regulation of the nuclear factor-kappaB antiapoptotic activity in human gliomas. Conti A; Ageunnouz M; La Torre D; Cardali S; Angileri FF; Buemi C; Tomasello C; Iacopino DG; D'Avella D; Vita G; Tomasello F J Neurosurg; 2005 Nov; 103(5):873-81. PubMed ID: 16304992 [TBL] [Abstract][Full Text] [Related]
3. Expression of survivin in astrocytic tumors: correlation with malignant grade and prognosis. Kajiwara Y; Yamasaki F; Hama S; Yahara K; Yoshioka H; Sugiyama K; Arita K; Kurisu K Cancer; 2003 Feb; 97(4):1077-83. PubMed ID: 12569609 [TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor-alpha induces the expression of DR6, a member of the TNF receptor family, through activation of NF-kappaB. Kasof GM; Lu JJ; Liu D; Speer B; Mongan KN; Gomes BC; Lorenzi MV Oncogene; 2001 Nov; 20(55):7965-75. PubMed ID: 11753679 [TBL] [Abstract][Full Text] [Related]
5. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively. Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597 [TBL] [Abstract][Full Text] [Related]
6. TRAF2-binding BIR1 domain of c-IAP2/MALT1 fusion protein is essential for activation of NF-kappaB. Garrison JB; Samuel T; Reed JC Oncogene; 2009 Apr; 28(13):1584-93. PubMed ID: 19234489 [TBL] [Abstract][Full Text] [Related]
7. Correlation of the expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1 (TNFR 1) and c-Myc with the clinical course in the treatment of malignant astrocytomas with recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2). Yamamoto M; Fukushima T; Hayashi S; Ikeda K; Tsugu H; Kimura H; Soma G; Tomonaga M Anticancer Res; 2000; 20(1C):611-8. PubMed ID: 10769704 [TBL] [Abstract][Full Text] [Related]
8. Expression of the constitutively activated RelA/NF-kappaB in human astrocytic tumors and the in vitro implication in the regulation of urokinase-type plasminogen activator, migration, and invasion. Tsunoda K; Kitange G; Anda T; Shabani HK; Kaminogo M; Shibata S; Nagata I Brain Tumor Pathol; 2005; 22(2):79-87. PubMed ID: 18095109 [TBL] [Abstract][Full Text] [Related]
9. Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma. Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Yeap BY; Sugarbaker DJ; Bueno R J Pathol; 2007 Mar; 211(4):439-46. PubMed ID: 17253597 [TBL] [Abstract][Full Text] [Related]
10. TACI induces cIAP1-mediated ubiquitination of NIK by TRAF2 and TANK to limit non-canonical NF-kappaB signaling. Kanno Y; Sakurai D; Hase H; Kojima H; Kobata T J Recept Signal Transduct Res; 2010 Apr; 30(2):121-32. PubMed ID: 20184394 [TBL] [Abstract][Full Text] [Related]
11. Quantitative evaluation of the apoptosis regulating genes Survivin, Bcl-2 and Bax in inflammatory and malignant pleural lesions. Falleni M; Pellegrini C; Marchetti A; Roncalli M; Nosotti M; Palleschi A; Santambrogio L; Coggi G; Bosari S Lung Cancer; 2005 May; 48(2):211-6. PubMed ID: 15829320 [TBL] [Abstract][Full Text] [Related]
12. Antiandrogen-like actions of an antioxidant on survivin, Bcl-2 and PSA in human prostate cancer cells. Gunawardena K; Campbell LD; Meikle AW Cancer Detect Prev; 2005; 29(4):389-95. PubMed ID: 16139439 [TBL] [Abstract][Full Text] [Related]
13. AWP1 binds to tumor necrosis factor receptor-associated factor 2 (TRAF2) and is involved in TRAF2-mediated nuclear factor-kappaB signaling. Chang EJ; Ha J; Kang SS; Lee ZH; Kim HH Int J Biochem Cell Biol; 2011 Nov; 43(11):1612-20. PubMed ID: 21810480 [TBL] [Abstract][Full Text] [Related]
14. TRAF1 is involved in the classical NF-kappaB activation and CD30-induced alternative activity in Hodgkin's lymphoma cells. Guo F; Sun A; Wang W; He J; Hou J; Zhou P; Chen Z Mol Immunol; 2009 Aug; 46(13):2441-8. PubMed ID: 19540595 [TBL] [Abstract][Full Text] [Related]
15. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma. Ikeguchi M; Hirooka Y; Kaibara N Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288 [TBL] [Abstract][Full Text] [Related]
16. Human RPE expression of cell survival factors. Yang P; Wiser JL; Peairs JJ; Ebright JN; Zavodni ZJ; Bowes Rickman C; Jaffe GJ Invest Ophthalmol Vis Sci; 2005 May; 46(5):1755-64. PubMed ID: 15851579 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of survivin reduces cell proliferation and induces apoptosis in human endometrial cancer. Ai Z; Yin L; Zhou X; Zhu Y; Zhu D; Yu Y; Feng Y Cancer; 2006 Aug; 107(4):746-56. PubMed ID: 16826583 [TBL] [Abstract][Full Text] [Related]
18. NF-kappaB protects Behçet's disease T cells against CD95-induced apoptosis up-regulating antiapoptotic proteins. Todaro M; Zerilli M; Triolo G; Iovino F; Patti M; Accardo-Palumbo A; di Gaudio F; Turco MC; Petrella A; de Maria R; Stassi G Arthritis Rheum; 2005 Jul; 52(7):2179-91. PubMed ID: 15986355 [TBL] [Abstract][Full Text] [Related]
19. Apoptosis and proliferation markers in diffusely infiltrating astrocytomas: profiling of 17 molecules. Liu X; Chen N; Wang X; He Y; Chen X; Huang Y; Yin W; Zhou Q J Neuropathol Exp Neurol; 2006 Sep; 65(9):905-13. PubMed ID: 16957584 [TBL] [Abstract][Full Text] [Related]
20. Overexpression of alpha4 chain-containing laminins in human glial tumors identified by gene microarray analysis. Ljubimova JY; Lakhter AJ; Loksh A; Yong WH; Riedinger MS; Miner JH; Sorokin LM; Ljubimov AV; Black KL Cancer Res; 2001 Jul; 61(14):5601-10. PubMed ID: 11454714 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]